Nefopam does not influence onset and recovery profiles of rocuronium-induced neuromuscular block: a prospective, double-blinded, randomized, controlled study
Anesthesia and Pain Medicine
;
: 286-291, 2018.
Article
in English
| WPRIM
| ID: wpr-715756
ABSTRACT
BACKGROUND:
We investigated the hypothesis that pretreatment with nefopam 20 mg would influence the onset and recovery profiles of rocuronium-induced neuromuscular block.METHODS:
After Institutional Review Board approval, 134 patients, aged between 20–65 years, belonging to the American Society of Anesthesiologists physical status classification I or II, were randomly allocated to receive either 0.9% normal saline (control group) or nefopam 20 mg (nefopam group), infused over one hour before induction of anesthesia. Anesthesia was induced with remifentanil and propofol, followed by endotracheal intubation with rocuronium 0.6 mg/kg. We recorded the lag time, onset time, clinical duration, recovery index, recovery time, and total recovery time.RESULTS:
We included 111 patients in the final analysis. The lag time, onset time, clinical duration, recovery index, recovery time, and total recovery time of the nefopam group (n = 57) were not significantly different compared with that of the control group (n = 54).CONCLUSIONS:
Pretreatment with nefopam 20 mg one hour before induction of anesthesia does not have a significant influence on the onset and recovery profiles of rocuronium-induced neuromuscular block.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Propofol
/
Prospective Studies
/
Classification
/
Neuromuscular Nondepolarizing Agents
/
Neuromuscular Blockade
/
Ethics Committees, Research
/
Drug Interactions
/
Neuromuscular Monitoring
/
Intubation, Intratracheal
/
Anesthesia
Type of study:
Controlled clinical trial
/
Observational study
Limits:
Humans
Language:
English
Journal:
Anesthesia and Pain Medicine
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS